Spectranetics has a total of 579 patents globally, out of which 388 have been granted. Of these 579 patents, more than 58% patents are active. The United States of America is where Spectranetics has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Spectranetics.
Spectranetics is subpart of Philips was founded in the year 1984. The Company develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Company’s CVX-300 excimer laser system is used in applications such as coronary angioplasty and the removal of pacemaker leads. Spectranetics is also developing other applications in restenosis stents and peripheral vascular applications.
Do read about some of the most popular patents of Spectranetics which have been covered by us in this article and also you can find Spectranetics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Spectranetics patent portfolio.
How many patents does Spectranetics have?
Spectranetics has a total of 579 patents globally. These patents belong to 129 unique patent families. Out of 579 patents, 338 patents are active.
How Many Patents did Spectranetics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Spectranetics Applications Filed | Spectranetics Patents Granted |
2023 | 1 | 7 |
2022 | 1 | 13 |
2021 | 5 | 30 |
2020 | 6 | 40 |
2019 | 12 | 44 |
2018 | 18 | 49 |
2017 | 49 | 34 |
2016 | 47 | 31 |
2015 | 91 | 34 |
2014 | 51 | 19 |
2013 | 66 | 12 |
2012 | 12 | 10 |
2011 | 26 | 21 |
How many Spectranetics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Spectranetics File in Different Countries?
Countries in which Spectranetics Filed Patents
Country | Patents |
United States Of America | 287 |
Europe | 70 |
Germany | 43 |
Japan | 35 |
Austria | 35 |
China | 9 |
Hong Kong (S.A.R.) | 9 |
Australia | 7 |
United Kingdom | 5 |
Canada | 5 |
Spain | 4 |
Korea (South) | 4 |
New Zealand | 4 |
Russia | 3 |
Brazil | 2 |
Italy | 2 |
India | 1 |
Where are Research Centers of Spectranetics Patents Located?
10 Best Spectranetics Patents
US8097012B2 is the most popular patent in the Spectranetics portfolio. It has received 278 citations so far from companies like Ethicon Endo-Surgery Inc, and Cilag Gmbh International.
Below is the list of 10 most cited patents of Spectranetics:
Publication Number | Citation Count |
US8097012B2 | 278 |
US7303533B2 | 179 |
US9668765B2 | 167 |
US20050177130A1 | 152 |
US6852109B2 | 144 |
US20090105687A1 | 141 |
US7686824B2 | 140 |
US6970732B2 | 126 |
US6772014B2 | 122 |
US6752800B1 | 122 |
How many inventions of other companies were rejected due to Spectranetics patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Spectranetics invention. They couldn’t because Spectranetics had protected those before them.
Examiners at the USPTO referred 81 Spectranetics patents in 471 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Spectranetics patent portfolio are Boston Scientific, Medtronic and Cook Medical Technologies.
List of the Companies whose Patents were rejected citing Spectranetics –
Company | Number of Patent Applications that faced Rejection Citing Spectranetics Patents | Number of Rejections (102 & 103) |
Boston Scientific | 20 | 50 |
Medtronic | 12 | 23 |
Cook Medical Technologies | 10 | 17 |
Teleflex Life Sciences | 10 | 41 |
Bolt Medical Inc | 8 | 14 |
Covidien | 7 | 15 |
Eximo Medical Ltd | 5 | 9 |
Xablecath Inc | 4 | 5 |
Abbott | 4 | 8 |
Biotronik Ag | 3 | 4 |
Count of 102 and 103 Type Rejections based on Spectranetics Patents
Top Spectranetics Patents used in Rejecting Most Patent Applications
Patent Number | Count of Rejected Applications |
US10842567B2 | 10 |
US9028520B2 | 9 |
US7931663B2 | 8 |
US7691119B2 | 7 |
US20050177130A1 | 7 |
US9066742B2 | 7 |
US8956376B2 | 6 |
US8998936B2 | 5 |
US8414568B2 | 5 |
US7686824B2 | 5 |
US9320530B2 | 5 |
US6951554B2 | 5 |
US9375328B2 | 5 |
US8080026B2 | 5 |
US9814862B2 | 5 |
What Percentage of Spectranetics US Patent Applications were Granted?
Spectranetics (Excluding its subsidiaries) has filed 311 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 266 have been granted leading to a grant rate of 89.8%.
Below are the key stats of Spectranetics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Spectranetics?
Law Firm | Total Applications | Success Rate |
Philips Intellectual Property & Standards | 234 | 93.86% |
Kilpatrick Townsend & Stockton Llp | 25 | 82.61% |
Faegre Baker Daniels Llp | 15 | 66.67% |
Pillsbury Winthrop Shaw Pittman | 8 | 85.71% |
Fishman Stewart Pllc | 6 | 60.00% |
Dan Rottenberg | 5 | 0% |
Cushman Darby & Cushman | 3 | 33.33% |
Flehr Hohbach Test | 2 | 100.00% |
Armstrong Teasdale Schlafly & Davis | 1 | 100.00% |
Carter Deluca & Farrell Llp | 1 | 0.00% |
What are Spectranetics key innovation segments?
What Technologies are Covered by Spectranetics?
The chart below distributes patents filed by Spectranetics